Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.
Moderna laid out sales expectations for the coming year on Monday that were below even the much-diminished Wall Street expectations. The stock was falling 14% to $35.71 in premarket trading. The biotech that became a household name during the Covid-19 pandemic in 2020 has struggled to regain its footing as the market for Covid-19 vaccines has collapsed.
Moderna Stock Plunges After Vaccine Sales Struggle
Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to be sluggish.
Moderna's $1 Billion Revenue Forecast Cut Sends Stock Plummeting Over 20%
Key Takeaways Moderna shares tumbled Monday after the company cut its 2025 revenue forecast by $1 billion.The company expects much of its revenue to be realized in the back half of the year from its Covid-19 and RSV vaccines.
Moderna cuts 2025 sales forecast by $1B on weak vaccine demand
Moderna cut its 2025 sales forecast by $1 billion today, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares down more than 18% in premarket trading.
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative.
Jewish Voice for Peace to pay over $600,000 to settle COVID-19 loan fraud allegation
JVP will be paying twice the amount it received for a $338,817 second-draw loan under the Paycheck Protection Act Program.
Arizona business owner sentenced to prison after using COVID-19 loans on home, travel
A 51-year-old business owner is going to prison after a conviction of fraud for misusing COVID-19 loans from the government.
How to protect yourself from norovirus, COVID-19, flu and RSV during the winter surge
There’s no medication for norovirus. Instead, you’ll need to rehydrate as much as possible with water and other liquids. Seek ...
The American Journal of Managed Care1d
Study Finds Link Between COVID-19 and Elevated Risk of GI Disorders
COVID-19 patients show a 37% higher risk of developing new gastrointestinal disorders compared to COVID-19-negative ...
People’s Pharmacy: Could this medication help post-COVID-19 brain fog?
Scientists do not appear to have studied valacyclovir for post-COVID-19 brain fog. Another reader found valacyclovir helpful, ...
Newsweek on MSN9d
What Will Happen to COVID-19 in 2025? Experts Explain
Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.
Did Yale Scientists Find COVID-19 Spike Proteins in Vaccinated People? What We Know About Rumor
Speculation about the alleged findings of a study on long COVID and post-vaccination syndrome spread widely among vaccine ...
What To Do If You Test Positive For COVID-19
During the current "silent" COVID-19 surge, you are at greater risk for getting infected with the SARS-CoV-2. Here's what to ...
Record 36.8 million tourists visited Japan in 2024 in return to pre-Covid-19 boom
The country logged more than 36.8 million tourist arrivals in 2024, topping 2019’s record of nearly 32 million, according to ...
New Scientist11d
Will there be another pandemic after covid-19 and are we prepared?
Covid-19 is responsible for the deaths of millions of people around the world, but researchers fear the next global outbreak ...
The mystery of why Covid-19 seems to be becoming milder
The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...
At The Movies: Joyful threequel Paddington In Peru, Covid-19 horror story in An Unfinished Film
Reviews of the animated live-action family adventure and award winner from Chinese cinema maverick Lou Ye. Read more at ...